Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug

European Journal of Pharmacology

Volumn 467, Issue 1-3, 2003, Pages 173-183

  Tubaro, Ezio ^a   Belogi, Luisella ^a   Mezzadri, Carla Maria ^a   Bettelli, Enzo ^a  

^a Medosan Ricerca Srl   (Italy)

Author keywords

(Rat); Amtolmetin guacyl; Inflammation; Intestine; Neuropeptide

Indexed keywords

ACETIC ACID; AMTOLMETIN GUACIL; CAPSAZEPINE; INDOMETACIN; MALONALDEHYDE; MESALAZINE; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NABUMETONE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TOLMETIN; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; COLITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME BLOOD LEVEL; GUINEA PIG; HEALING; ILEITIS; INTESTINE; INTESTINE WALL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STOMACH PROTECTION; TREATMENT OUTCOME;

EID: 0037466416     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01598-X     Document Type: Article

References (45)

1. Bartho L., Petho G., Antal A., Holzer P., Szolcsanyi J. Two types of relaxation due to capsaicin in the guinea pig isolated ileum. Neurosci. Lett. 16:1987;146-150.
2. Bianchi Porro G., Montrone F., Lazzaroni M., Manzionna G., Caruso I. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis. Ital. J. Gastroenterol. Hepatol. 3:1999;378-385.
3. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:1982;206-209.
4. Brodie D.A., Cook P.G., Bauer B.J., Dagle G.E. Indomethacin-induced intestinal lesions in the rat. Toxicol. Appl. Pharmacol. 17:1970;615-624.
5. Chen R.Y., Guth P.H. Stimulation of capsaicin-sensitive nerves induces gastric mucosal hyperemia, which is mediated in part by both calcitonin gene-related peptide (CGRP) and nitric oxide (NO). Am. J. Physiol. 268:1995;791-796.
6. Cuzzocrea S., Mazzon E., Serraino I., Lepore V., Terranova M.L., Ciccolo A., Caputi A.P. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J. Pineal Res. 30:2001;1-2.
7. Evangelista S., Meli A. Influence of capsaicin-sensitive fibres on experimentally-induced colitis in rats. J. Pharm. Pharmacol. 41:1989;574-575.
8. Evangelista S., Maggi C.A., Meli A. Involvement of capsaicin-sensitive mechanism(s) in the antiulcer defence of intestinal mucosa in rats. Proc. Soc. Exp. Biol. Med. 184:1987;264-266.
9. Fox-Orenstein A.E., Grider J.R. Regulation of colonic propulsion by enteric excitatory and inhibitory neurotransmitters. Am. J. Physiol. 271:1996;433-437.
10. Ghirardini M., Betelemme L., Fatti F., Bonollo L., Martini A. Evaluation of the gastric tolerability of MED15 in comparison with indomethacin: double blind study in healthy volunteers. Drugs Expl. Clin. Res. XVI:1990;19-24. (Supplement).
11. Ginzberg H.H., Cherapanov V., Dong Q., Cantin A., McCulloch C.A., Shannon P.T., Downey G.P. Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;705-717.
12. Gonella J. The physiological role of peripheral serotoninergic neurones. A review. J. Physiol. 77:1981;2-39.
13. Holzer P., Lippe I.T. Capsaicin inhibits ethanol-induced gastric damage. Ablation of capsaicin-sensitive afferent neurons enhances experimental gastric ulceration. Neuroscience. 27:1988;981-987.
14. Holzer P., Sametz W. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology. 91:1986;975-981.
15. Holzer P., Pabst M.A., Lippe I.T., Peskar B.M., Peskar B.A., Livingston E.H., Guth P.H. Afferent nerve-mediated protection from ethanol. Gastroenterology. 98:1990;838-848.
16. Holzer P., Peskar B.M., Peskar B.A., Amann R. CGRP is the only vasodilator peptide released in the stomach by capsaicin. Neurosci. Lett. 108:1990;195-200.
17. Holzer P., Lippe I.T., Jocl M., Wachter C., Erb R., Heinemann A. Nitric oxide-dependent and independent hyperaemia due to calcitonin gene-related peptide in the rat stomach. Br. J. Pharmacol. 110:1993;404-410.
18. Kinoshita Y., Inui T., Chiba T. Calcitonin gene-related peptide: a neurotransmitter involved in capsaicin-sensitive afferent nerve-mediated gastric mucosal protection. J. Clin. Gastroenterol. 17(Suppl. 1):1993;27-32.
19. Kucharzik T., Lugering A., Lugering N., Rautemberg K., Linnepe M., Cichon C., Reichelt R., Stoll R., Schmidt M.A., Domschke W. Characterization of M cell development during indomethacin-induced ileitis in rats. Aliment. Pharmacol. Ther. 14:2000;247-256.
20. Kullman F., Gross V., Ruschoff J., Arndt H., Benda W., Winkler von Mohrenfels A., Schölmerich J. Effect of ursodoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats. Z. Gastroenterol. 35:1997;171-178.
21. Lanza F.L. A safe non-steroidal anti-inflammatory drug - the search continues. Ital. J. Gastroenterol. Hepatol. 31:1999;386-387.
22. Louis E., Belaich G.J. Experimental models of inflammatory bowel disease. Acta Gastroenterol. Belg. 57:1994;306-309.
23. Maggi C.A., Santicioli P., Del Bianco E., Geppetti P., Barbanti G., Turini D., Meli A. Release of VIP- but not CGRP-like immunoreactivity by capsaicin from the isolated small intestine. Neurosci. Lett. 10:1989;317-320.
24. Marcolongo R., Frediani B., Biasi G., Minari C., Barreca C. Metanalysis of the tolerability of amtolmetin guacyl, a new, efficacious, non-steroidal anti-inflammatory drug, compared with traditional NSAIDs. Clin. Drug Invest. 17:1999;89-96.
25. Matusak O., Bauer V. Action of histamine on nerve mediated responses of the guinea-pig ileum. Agents Actions. 23:1988;244-246.
26. McCafferty D.M., Wallace J.L., Sharkey K.A. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am. J. Physiol. 272:1997;272-280.
27. Montrone F., Santandrea S., Caruso I., Gerli R., Cesarotti M.E., Frediani P., Bassani R. Amtolmetin guacyl versus piroxicam in patients with osteoarthritis. J. Int. Med. Res. 28:2000;91-100.
28. Morris G.P., Beck P.L., Merridge M.S., Depew W.T., Szewczuk M.R., Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 96:1989;759-803.
29. Musch M.W., Kachur J.F., Miller R.J., Field M., Stoff J.S. Bradykinin-stimulated electrolyte secretion in rabbit and guinea pig intestine. Involvement of arachidonic acid metabolites. J. Clin. Invest. 71:1983;1073-1083.
30. Petazzi I., Corberi G., Bonollo L., Martini A. Clinical study of the therapeutic activity and of the tolerability of Artromed in comparison with naproxen in patients with osteoarthritis in different localizations. Drugs Expl. Clin. Res. XVI:1990;25-30. (Supplement).
31. Petazzi I., Corberi G., Bonollo L., Martini A. Evaluation of the time course of the algic-inflammatory symptomatology in patients with osteoarthritic afflictions during and after treatment with Artromed or diclofenac. Drugs Expl. Clin. Res. XVI:1990;7-12. (Supplement).
32. Pisano C., Grandi D., Morini G., Coppelli G., Vesci L., Lo Giudice P., Pace S., Pacifici L., Longo A. Gastrosparing effect of new anti-inflammatory drug amtolmetin guacyl in the rat: involvement of nitric oxide. Dig. Dis. Sci. 44:1999;713-724.
33. Riezzo G., Chiloiro M., Montanaro S. Protective effect of amtolmetin guacyl versus placebo, a typical NSAID, and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage. Dig. Dis. Sci. 46:2001;1797-1804.
34. Roberts P.J., Riley G.P., Morgan K., Miller R., Hunter J.O., Middleton S.J. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J. Clin. Pathol. 54:2001;293-297.
35. Rolfe V.E., Levin R.J. Neuronal and non-neuronal activation of electrogenic secretion by 5-hydroxytryptamine in the rat ileum in vitro. Acta Physiol. Scand. 162:1998;469-474.
36. Sharon P., Stenson W.F. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. Gastroenterology. 88:1985;55-63.
37. Simon L.S., Lanza F.L., Lipsky P.E., Hubbard R.C., Talwalker S., Schwartz B.D., Isakson P.C., Geis G.S. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum. 41:1998;1591-1602.
38. Stein R.D., Genovesi S., Demarest K.T., Weaver L.C. Capsaicin treatment attenuates the reflex excitation of sympathetic activity caused by chemical stimulation of intestinal afferent nerves. Brain Res. 5:1986;145-151.
39. Szepes Z., Kiss J., Molnar T., Lamarque D., Jancso G., Laszlo F. Capsaicin-sensitive mechanisms in the modulation of rat colonic vascular permeability under physiological and pathological conditions. J. Physiol. (Paris). 91:1997;123-126.
40. Tubaro E., Belogi L., Mezzadri C.M., Ruco L., Stopacciaro A. Studies on the gastric tolerability of the new nonsteroidal anti-inflammatory drug amtolmetin guacyl. Arzneim.-Forsch. Drug Res. 45:1995;1298-1302.
41. Tubaro E., Belogi L., Mezzadri C.M. The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug. Eur. J. Pharmacol. 387:2000;233-244.
42. Tubaro E., Belogi L., Mezzadri C.M. Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug. Arzneim.-Forsch. Drug Res. 51:2001;737-742.
43. Virus R.M., Gebhart G.F. Pharmacologic actions of capsaicin: apparent involvement of substance P and serotonin. Life Sci. 25:1979;1273-1283.
44. Whittle B.J., Lopez-Belmonte J., Moncada S. Nitric oxide mediates rat mucosal vasodilation induced by intragastric capsaicin. Eur. J. Pharmacol. 218:1995;339-341.
45. Yamada T., Deitch E., Specian R.D., Perry M.A., Sartor R.B., Grisham M.B. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 17:1993;641-662.